enGene Therapeutics Inc (ENGN) Unusual Options Activity Today

Checking ENGN unusual options activity helps you spot when traders are making outsized bets on enGene Therapeutics Inc before the broader market catches on. enGene Therapeutics Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor ENGN unusual options activity today and surface the prints that deserve a second look.

Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching ENGN unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking ENGN unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and ENGN unusual options flow data becomes especially valuable around earnings, product launches, and macro events.

enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines through the delivery of therapeutics to mucosal tissues and other organs. Its lead product candidate is EG-70 (detalimogene voraplasmid), which is a non-viral immunotherapy to treat non-muscle invasive bladder cancer patients with carcinoma-in-situ (Cis), who are unresponsive to treatment with Bacillus Calmette-Guérin. The company was founded in 2023 and is based in Saint-Laurent, Canada.

Catalysts rarely arrive without a footprint, and ENGN unusual options activity is often where that footprint shows up first. Our scanner tracks enGene Therapeutics Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at ENGN unusual options volume on the call side or chasing put sweeps, enGene Therapeutics Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.